📊 DHCNL Key Takeaways
Is Diversified Healthcare Trust (DHCNL) a Good Investment?
Diversified Healthcare Trust is experiencing severe operational distress with substantial net losses, negative free cash flow of -1.2B, and deteriorating cash generation despite modest revenue growth. The company's negative net margin of -18.6%, minimal interest coverage of 0.2x, and operating cash flow deficit indicate fundamental business challenges that threaten financial viability and debt service capacity.
Diversified Healthcare Trust shows only modest top-line growth, but that revenue is not translating into durable profitability or cash generation. Operating margin is thin, net losses remain large, and interest coverage of 0.2x signals severe debt-service pressure. With negative operating cash flow, extremely negative free cash flow, and heavy leverage, the fundamental profile points to elevated financial risk rather than improving business quality.
Why Buy Diversified Healthcare Trust Stock? DHCNL Key Strengths
- Modest revenue growth of 2.8% YoY demonstrates some market demand
- Positive operating income of 41.7M shows potential profitability at operational level
- Reasonable asset base of 4.4B provides collateral and business foundation
- Revenue grew 2.8% year over year, indicating some stabilization in the asset base
- Operating income is positive at $41.71M, showing the portfolio can still generate property-level earnings
- Stockholders' equity of $1.67B provides some balance-sheet asset backing
DHCNL Stock Risks: Diversified Healthcare Trust Investment Risks
- Severe net losses of -285.9M with -18.6% net margin indicate structural unprofitability
- Negative free cash flow of -1.2B and negative operating cash flow of -19.6M threaten debt service and sustainability
- Dangerously low interest coverage ratio of 0.2x with 2.4B long-term debt creates acute default risk
- High leverage with 1.47x debt-to-equity ratio combined with negative returns (ROE -17.2%, ROA -6.6%)
- Capital expenditure of 1.2B against negative operating cash flow indicates unsustainable capital allocation
- Net margin of -18.6% and ROE of -17.2% reflect persistently weak profitability
- Interest coverage of 0.2x and long-term debt of $2.44B indicate substantial refinancing and solvency risk
- Operating cash flow of -$19.62M and free cash flow of -$1.18B show poor cash generation and heavy capital demands
Key Metrics to Watch
- Operating cash flow trajectory and return to positive generation
- Interest coverage ratio improvement and debt service capability
- Path to net profitability and net margin expansion
- Free cash flow conversion and working capital management
- Debt reduction progress and leverage ratio improvement
- Interest coverage and debt refinancing progress
- Operating cash flow trend relative to capital expenditures
Diversified Healthcare Trust (DHCNL) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
DHCNL Profit Margin, ROE & Profitability Analysis
DHCNL vs Real Estate Sector: How Diversified Healthcare Trust Compares
How Diversified Healthcare Trust compares to Real Estate sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Diversified Healthcare Trust Stock Overvalued? DHCNL Valuation Analysis 2026
Based on fundamental analysis, Diversified Healthcare Trust shows some fundamental concerns relative to the Real Estate sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Diversified Healthcare Trust Balance Sheet: DHCNL Debt, Cash & Liquidity
DHCNL Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Diversified Healthcare Trust's revenue has remained relatively flat over the 5-year period, with a 6% decline. The most recent EPS of $-1.23 indicates the company is currently unprofitable.
DHCNL Revenue Growth, EPS Growth & YoY Performance
DHCNL Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $373.6M | -$9.0M | $-0.41 |
| Q2 2025 | $371.4M | -$9.0M | $-0.38 |
| Q1 2025 | $370.8M | -$9.0M | $-0.04 |
| Q3 2024 | $356.5M | -$52.7M | $-0.28 |
| Q2 2024 | $346.2M | -$52.7M | $-0.30 |
| Q1 2024 | $346.0M | -$52.7M | $-0.22 |
| Q3 2023 | $322.9M | $49.5M | $0.21 |
| Q2 2023 | $313.0M | -$72.6M | $-0.30 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Diversified Healthcare Trust Dividends, Buybacks & Capital Allocation
DHCNL SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Diversified Healthcare Trust (CIK: 0001075415)
📋 Recent SEC Filings
❓ Frequently Asked Questions about DHCNL
What is the AI rating for DHCNL?
Diversified Healthcare Trust (DHCNL) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 92% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are DHCNL's key strengths?
Claude: Modest revenue growth of 2.8% YoY demonstrates some market demand. Positive operating income of 41.7M shows potential profitability at operational level. ChatGPT: Revenue grew 2.8% year over year, indicating some stabilization in the asset base. Operating income is positive at $41.71M, showing the portfolio can still generate property-level earnings.
What are the risks of investing in DHCNL?
Claude: Severe net losses of -285.9M with -18.6% net margin indicate structural unprofitability. Negative free cash flow of -1.2B and negative operating cash flow of -19.6M threaten debt service and sustainability. ChatGPT: Net margin of -18.6% and ROE of -17.2% reflect persistently weak profitability. Interest coverage of 0.2x and long-term debt of $2.44B indicate substantial refinancing and solvency risk.
What is DHCNL's revenue and growth?
Diversified Healthcare Trust reported revenue of $1.5B.
Does DHCNL pay dividends?
Diversified Healthcare Trust pays dividends, with $9.7M distributed to shareholders in the trailing twelve months.
Where can I find DHCNL SEC filings?
Official SEC filings for Diversified Healthcare Trust (CIK: 0001075415) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is DHCNL's EPS?
Diversified Healthcare Trust has a diluted EPS of $-1.19.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is DHCNL a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Diversified Healthcare Trust has a STRONG SELL rating with 92% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is DHCNL stock overvalued or undervalued?
Valuation metrics for DHCNL: ROE of -17.2% (sector avg: 8%), net margin of -18.6% (sector avg: 20%). Compare these metrics with sector averages to assess valuation.
Should I buy DHCNL stock in 2026?
Our dual AI analysis gives Diversified Healthcare Trust a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is DHCNL's free cash flow?
Diversified Healthcare Trust's operating cash flow is $-19.6M, with capital expenditures of $1.2B. FCF margin is -76.6%.
How does DHCNL compare to other Real Estate stocks?
Vs Real Estate sector averages: Net margin -18.6% (avg: 20%), ROE -17.2% (avg: 8%), current ratio N/A (avg: 1.5).